Overview
AI supports large scale screening by automating detection and prioritization of abnormal studies. It aims to improve sensitivity and reduce workload for screening programs. Careful evaluation ensures net benefit at population level.
Program Design
Integration with recall pathways and follow up protocols is essential for screening programs. Thresholds and triage rules are tailored to program goals and resources. Monitoring of outcomes and harms guides adjustments.
Cost Effectiveness
Economic analyses assess AI impact on screening costs and downstream testing. Savings from reduced workload must be balanced against implementation and maintenance costs. Pilot studies inform scale up decisions.
Equity Considerations
Screening AI must be validated across diverse populations to avoid widening disparities. Access to supplemental testing and follow up care influences program success. Transparent reporting supports public trust.